SPAC Overview
Timeline Progress
- Registration2023-05-26 Filed S1
- IPO2023-12-05 IPO, search begins
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
Aimei Health Technology Co., Ltd. is a blank-check company seeking a business combination. Its intended focus is small-cap healthcare innovation businesses, particularly in biopharmaceuticals, medical technology/devices, diagnostics and related services.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
North America, Europe, Asia Pacific
The terms and the filing trail behind Aimei Health Technology Co., Ltd.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team includes CEO Juan Fernandez Pascual, with automotive and industrial leadership experience and prior SPAC COO experience, and CFO Heung Ming Wong, with extensive finance, accounting and public-company director experience. Its director nominees bring experience in accounting, auditing, healthcare, business operations, private equity, and real estate.